Corbion delivers Sales of € 645.6 million and an improvement of EBITDA margins of +300 bps for first-half 2025; full-year outlook maintained

Core Insights - Corbion reported its half-year 2025 results, highlighting a focus on sustainable ingredients and scientific preservation [1] Financial Performance - Organic sales growth for H1 2025 was +2.9%, with Q2 showing a decline of -1.6% [2] - Volume/mix growth was +3.3% in H1 2025, while Q2 experienced a decrease of -1.3% [2] - Price changes reflected a slight decrease of -0.4% in H1 2025, with Q2 at -0.3% [2] - Total sales reached €645.6 million in H1 2025, compared to €637.1 million in H1 2024, marking a growth of +1.3% [2] - Adjusted EBITDA for H1 2025 was €106.6 million, up from €86.1 million in H1 2024, representing a growth of +23.8% [2] - Adjusted EBITDA organic growth was +29.3% [2] - Adjusted EBITDA margins improved by +300 basis points to 16.5% [2] - Operating profit increased to €63.5 million in H1 2025, a significant rise of +89.0% compared to €33.6 million in H1 2024 [2] - Cash flow from operating activities was €45.7 million, with Free Cash Flow at €12.1 million [2] Business Segments - Volume/mix growth was observed in both business segments [2] Outlook - The company maintained its FY 2025 outlook [2]